(Q34497913)

English

Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

quality of life

1 reference

based on heuristic

inferred from title

atopic dermatitis

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

McKenna SP

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Whalley D

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

de Prost Y

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Staab D

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Huels J

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

van Assche D

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

248-254

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Topical corticosteroid phobia in patients with atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

The Norwegian version of the Quality of Life Scale (QOLS-N). A validation and reliability study in patients suffering from psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Atopic dermatitis is associated with a decrement in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01383.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2006.01383.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16503881%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34497913&oldid=1577599319"